These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

204 related articles for article (PubMed ID: 16239575)

  • 1. Intranasal immunization strategy to impede pilin-mediated binding of Pseudomonas aeruginosa to airway epithelial cells.
    Hsieh JC; Tham DM; Feng W; Huang F; Embaie S; Liu K; Dean D; Hertle R; Fitzgerald DJ; Mrsny RJ
    Infect Immun; 2005 Nov; 73(11):7705-17. PubMed ID: 16239575
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Study of protective properties of recombinant atoxic form of exotoxin A and recombinant outer membrane protein F of Pseudomonas aeruginosa].
    Mikhaĭlova NA; Vertiev IuV; Kaloshin AA; Isakov MA
    Zh Mikrobiol Epidemiol Immunobiol; 2010; (2):39-44. PubMed ID: 20464999
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Active immunization using exotoxin A confers protection against Pseudomonas aeruginosa infection in a mouse burn model.
    Manafi A; Kohanteb J; Mehrabani D; Japoni A; Amini M; Naghmachi M; Zaghi AH; Khalili N
    BMC Microbiol; 2009 Feb; 9():23. PubMed ID: 19183501
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Non-toxic Pseudomonas aeruginosa exotoxin A expressing the FMDV VP1 G-H loop for mucosal vaccination of swine against foot and mouth disease virus.
    Challa S; Barrette R; Rood D; Zinckgraf J; French R; Silbart L
    Vaccine; 2007 Apr; 25(17):3328-37. PubMed ID: 17276557
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mucosal administration of a chimera composed of Pseudomonas exotoxin and the gp120 V3 loop sequence of HIV-1 induces both salivary and serum antibody responses.
    Mrsny RJ; Daugherty AL; Fryling CM; FitzGerald DJ
    Vaccine; 1999 Mar; 17(11-12):1425-33. PubMed ID: 10195778
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Preparation of recombinant atoxic form of exotoxin A from Pseudomonas aeruginosa.
    Kaloshin AA; Isakov MA; Mikhailova NA; Vertiev JV
    Bull Exp Biol Med; 2013 Jan; 154(3):346-50. PubMed ID: 23484197
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Exotoxin A-PLGA nanoconjugate vaccine against Pseudomonas aeruginosa infection: protectivity in murine model.
    Safari Zanjani L; Shapouri R; Dezfulian M; Mahdavi M; Shafiee Ardestani M
    World J Microbiol Biotechnol; 2019 Jun; 35(6):94. PubMed ID: 31187291
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The effect of anti-exotoxin A on the adherence of Pseudomonas aeruginosa to hamster tracheal epithelial cells in vitro.
    Moller PC; Evans MJ; Fader RC; Henson LC; Rogers B; Heggers JP
    Tissue Cell; 1994 Apr; 26(2):181-8. PubMed ID: 8023323
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Epithelial application of Pseudomonas aeruginosa exotoxin A results in a selective targeting to cells in the liver, spleen and lymph node.
    Daugherty AL; McKee ML; FitzGerald DJ; Mrsny RJ
    J Control Release; 2000 Mar; 65(1-2):297-302. PubMed ID: 10699289
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Therapeutic efficacy of Cintredekin Besudotox (IL13-PE38QQR) in murine lung fibrosis is unaffected by immunity to Pseudomonas aeruginosa exotoxin A.
    Rosada RS; Moreira AP; Frantz FG; Puri RK; Rahman A; Standiford TJ; Zárate-Bladés CR; Silva CL; Hogaboam CM
    PLoS One; 2010 Jan; 5(1):e8721. PubMed ID: 20090941
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dual-function vaccine for Pseudomonas aeruginosa: characterization of chimeric exotoxin A-pilin protein.
    Hertle R; Mrsny R; Fitzgerald DJ
    Infect Immun; 2001 Nov; 69(11):6962-9. PubMed ID: 11598071
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Host translational inhibition by Pseudomonas aeruginosa Exotoxin A Triggers an immune response in Caenorhabditis elegans.
    McEwan DL; Kirienko NV; Ausubel FM
    Cell Host Microbe; 2012 Apr; 11(4):364-74. PubMed ID: 22520464
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Production and properties evaluation of monoclonal antibodies against Pseudomonas aeruginosa exotoxin A].
    Soldatenkova AV; Iakovleva IV; Gavrilova NV; Mikhaĭlova NA; Sviridova VV
    Zh Mikrobiol Epidemiol Immunobiol; 2014; (1):30-5. PubMed ID: 24738291
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Is Pseudomonas aeruginosa exotoxin A a good carrier protein for conjugate vaccines?
    Pier GB
    Hum Vaccin; 2007; 3(2):39-40; author reply 41. PubMed ID: 17268204
    [No Abstract]   [Full Text] [Related]  

  • 15. Potent control of acute graft-versus-host disease lethality after immunization with a novel DNA vaccine targeted to B7-1/CD28 costimulatory signaling pathway.
    Luo Y; Liang F; Liu N; Xue H; Song X; Yuan F; Long J; Zhao X; Sun Y; Xi Y
    J Immunother; 2013 Feb; 36(2):82-92. PubMed ID: 23377669
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Respiratory infections with Pseudomonas aeruginosa in children with cystic fibrosis: early detection by serology and assessment of risk factors.
    West SE; Zeng L; Lee BL; Kosorok MR; Laxova A; Rock MJ; Splaingard MJ; Farrell PM
    JAMA; 2002 Jun; 287(22):2958-67. PubMed ID: 12052125
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Immunobiological properties of recombinant atoxic forms of the Pseudomonas aeruginosa exotoxin A].
    Isakov MA; Soldatenkova AS; Kaloshin AA; Mikhaĭlova NA
    Zh Mikrobiol Epidemiol Immunobiol; 2011; (2):37-42. PubMed ID: 21598613
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Production and characterization of human monoclonal antibody recognizing the N-terminal residues of Pseudomonas aeruginosa exotoxin A.
    Ohtsuka H; Horigome K; Ochi H; Nishimoto T; Kozuki T; Kato M; Okuda T; Noguchi H
    Hybridoma; 1991 Apr; 10(2):297-307. PubMed ID: 1651902
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Early immune response to the components of the type III system of Pseudomonas aeruginosa in children with cystic fibrosis.
    Corech R; Rao A; Laxova A; Moss J; Rock MJ; Li Z; Kosorok MR; Splaingard ML; Farrell PM; Barbieri JT
    J Clin Microbiol; 2005 Aug; 43(8):3956-62. PubMed ID: 16081936
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mice immunized with DNA encoding a modified Pseudomonas aeruginosa exotoxin A develop protective immunity against exotoxin intoxication.
    Shiau JW; Tang TK; Shih YL; Tai C; Sung YY; Huang JL; Yang HL
    Vaccine; 2000 Dec; 19(9-10):1106-12. PubMed ID: 11137245
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.